Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

• Главные авторы: Yuzaburo Inoue (Автор), Kanako Mitsunaga (Автор), Takeshi Yamamoto (Автор), Koki Chiba (Автор), Fumiya Yamaide (Автор), Taiji Nakano (Автор), Yoshinori Morita (Автор), Akiko Yamaide (Автор), Shuichi Suzuki (Автор), Takayasu Arima (Автор), Ken-ichi Yamaguchi (Автор), Minako Tomiita (Автор), Naoki Shimojo (Автор), Yoichi Kohno (Автор)
• Формат: ‌
• Опубликовано: BMC, 2018-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background Bisphosphonates are recommended for use as first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis in adults. However, the appropriate usage of bisphosphonates for the prevention or treatment of glucocorticoid-induced osteoporosis in children re...